Palatine Private Equity Fund V LP is a private investment fund based in Manchester, United Kingdom. Its most recent Form D, filed Aug 7, 2024, reports no sales yet. The filing does not set a minimum investment. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Anthony Dickin; Edmund Fazakerley; Gary Tipper.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Not stated
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Anthony Dickin; Edmund Fazakerley; Gary Tipper
- Latest Form D
- Aug 7, 2024
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Palatine Private Equity Fund V LP
What is the minimum investment for Palatine Private Equity Fund V LP?
Palatine Private Equity Fund V LP's latest Form D, filed Aug 7, 2024, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Palatine Private Equity Fund V LP?
Palatine Private Equity Fund V LP is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Palatine Private Equity Fund V LP raised?
Palatine Private Equity Fund V LP's latest Form D, filed Aug 7, 2024, reports no sales yet.
Where is Palatine Private Equity Fund V LP based?
Palatine Private Equity Fund V LP is based in Manchester, United Kingdom.
Size compared with every private investment fund
This fund hasn't reported any sales yet.